information Related products Suppliers

Proteins, soybean

SAFETY DATA SHEET
1. IDENTIFICATION OF THE PRODUCT AND THE COMPANY
: ELHIBIN?, 301-02
1.1 Product name and code
1.2 Recommended use : Cosmetic ingredient
1.3 Manufacturer : PENTAPHARM LTD.
Engelgasse 109
P.O. Box
CH-4002 Basel / Switzerland
Tel. ##41-61-706 48 48
Fax. ##41-61-319 96 19
1.4 Emergency phone number ##41-61-706 48 48

2. COMPOSITION AND INFORMATION ON INGREDIENTS

ELHIBIN? is a solution containing 80% of an aqueous soy
2.1 Chemical characterisation :
bean extract, 20% of glycerol (80%) and 0.1% of disodium
cocoamphodiacetate. ELHIBIN? is preserved using parabens
and phenoxyethanol.
2.2 Hazardous ingredients : None
2.3 Ingredients (INCI) CAS No EINECS No Reference
Soybean (Glycine Soja) Protein 9010-10-0 232-720-8 EINECS Database

3. HAZARD IDENTIFICATION
ELHIBIN?, used as a cosmetic ingredient, is not a hazardous material.
The data available do neither support any environmental hazard nor any adverse human health
hazard.

4. FIRST AID MEASURES
4.1 Skin Contact : Rinse with water.
4.2 Eye Contact : Rinse immediately with plenty of water.
4.3 Inhalation : Not applicable.
4.4 Ingestion : None, see 11.1.
4.5 Other first aid information : None known.

: ELHIBIN?
Product Name Product Code : 301-02
Issue Date : 22.11.2006 Replaces issue of : 7.06.2000
Version/Ref : 05 msp/bsu
Pentapharm Ltd, Engelgasse 109, P.O.Box, CH-4002 Basel/Switzerland
Phone: +41 61 706 48 48, Fax: +41 61 319 96 19, www.pentapharm.com
5. FIRE FIGHTING MEASURES
5.1 Extinguishing media : Water, carbon dioxide, foam, dry powder
5.2 Unsuitable extinguishing media : None known
5.3 Unusual fire fighting hazards : None known
5.4 Special fire fighting procedure : None known
5.5 Other recommendations : No special precautions and measures necessary.

6. ACCIDENTAL RELEASE MEASURES
: Avoid eye contact.
6.1 Personal precautions
6.2 Precautions to protect the : None
environment
6.3 Cleanup procedures : Dam large quantities and pump them into a container. For
the remaining amount use absorbent material. Small
quantities can be flushed with plenty of water into the
sewage system.

7. HANDLING AND STORAGE
: Avoid eye contact.
7.1 Handling precautions
7.2 Storage precautions : None
: Keep the product in a clean, cool and dark place.
7.3 Other information

8. EXPOSURE CONTROLS AND PERSONAL PROTECTION
8.1 Exposure controls : See 7.1
8.2 Engineering control measures : No special control measures necessary.
8.3 Personal protective equipment
Respiratory protection : None
Hand protection : Gloves
Eye protection : Safety glasses
Skin protection : Additional protective equipment is not normally required.
Other : ---

: ELHIBIN?
Product Name Product Code : 301-02
Issue Date : 22.11.2006 Replaces issue of : 7.06.2000
Version/Ref : 05 msp/bsu
Pentapharm Ltd, Engelgasse 109, P.O.Box, CH-4002 Basel/Switzerland
Phone: +41 61 706 48 48, Fax: +41 61 319 96 19, www.pentapharm.com
9. PHYSICAL AND CHEMICAL PROPERTIES
9.1 Appearance
Physical state : Liquid
Colour : Clear to slightly opalescent, yellowish liquid
Odour : Characteristic

9.2 Safety related information
pH : 5.2 - 6.0
Boiling point/boiling range : Approx. as water
Melting point/melting range : Not determined
Flash point : Not applicable
Flammability (solid, gas) : Not applicable
Autoflammability : Not applicable
Explosive properties : Not applicable
Oxidizing properties : Not applicable
Vapour pressure : approx. as water
Relative density : 1.052 - 1.062
Water solubility : Soluble
Fat solubility : Insoluble
n-octanol/water partition coefficient : Not determined
Vapour density (air = 1) : Not determined
Viscosity : Not determined
Volatiles : Water and Glycerol, approx. 95%

10. STABILITY AND REACTIVITY
10.1 Conditions to avoid : None known
10.2 Materials to avoid : None known
10.3 Hazardous decomposition products : None known

: ELHIBIN?
Product Name Product Code : 301-02
Issue Date : 22.11.2006 Replaces issue of : 7.06.2000
Version/Ref : 05 msp/bsu
Pentapharm Ltd, Engelgasse 109, P.O.Box, CH-4002 Basel/Switzerland
Phone: +41 61 706 48 48, Fax: +41 61 319 96 19, www.pentapharm.com
11. TOXICOLOGICAL INFORMATION
11.1 Possible dangerous-to-health effects
11.2 Skin contact : Neither irritative nor sensitizing.
11.3 Eye contact : Not irritative.
11.4 Inhalation : Not applicable.
11.5 Ingestion : Not toxic after oral ingestion.
11.6 Other information : Standard and well-defined safety testing has been
performed on ELHIBIN? which has proved the
product to be safe for cosmetic use

12. ECOLOGICAL INFORMATION
12.1 Mobility : Not determined
12.2 Persistence and degradability : Not determined
12.3 Bioaccumulative potential : Not determined
12.4 Ecotoxicity : Not determined
: ELHIBIN? is composed of physiological, biodegradable
12.5 Other information
compounds that are harmless when released into the
environment.

13. DISPOSAL CONSIDERATIONS
13.1 Product disposal : Neutralize and flush with plenty of water into the sewage
system.
13.2 Packaging disposal : Dispose of in a manner in accordance with local and
national regulations.

14. TRANSPORT INFORMATION
14.1 UN-No. : Not applicable
14.2 Road and rail transport (ADR/RID) : Not applicable
14.3 Air transport (ICAO/IATA-DGR) : Not applicable
14.4 Sea transport (IMO/IMDG) : Not applicable
14.5 Inland navigation (ADN/ADNR) : Not applicable
: ELHIBIN? is not classified as a dangerous material.
14.6 Other information

: ELHIBIN?
Product Name Product Code : 301-02
Issue Date : 22.11.2006 Replaces issue of : 7.06.2000
Version/Ref : 05 msp/bsu
Pentapharm Ltd, Engelgasse 109, P.O.Box, CH-4002 Basel/Switzerland
Phone: +41 61 706 48 48, Fax: +41 61 319 96 19, www.pentapharm.com
15. REGULATORY INFORMATION
15.1 Supply classification and labelling : No special packaging and labelling requirements.
15.2 National legislation : For further product information, we recommend
consideration of the corresponding appropriate National
Legislation.

16. OTHER INFORMATION
All information and instructions provided in this Safety Data Sheet are based on the current state of
scientific and technical knowledge at the date indicated on this Safety Data Sheet. PENTAPHARM
LTD. shall not be held responsible for any defect in the product covered by this Safety Data Sheet,
should the existence of such a defect not be detectable considering the current state of scientific and
technical knowledge.

: ELHIBIN?
Product Name Product Code : 301-02
Issue Date : 22.11.2006 Replaces issue of : 7.06.2000
Version/Ref : 05 msp/bsu
Pentapharm Ltd, Engelgasse 109, P.O.Box, CH-4002 Basel/Switzerland
Phone: +41 61 706 48 48, Fax: +41 61 319 96 19, www.pentapharm.com

;